
Illumina ILMN
€ 121.44
-3.26%
Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Illumina Langfristiger Schuldenstrom 2011-2026 | ILMN
Langfristiger Schuldenstrom Jährlich Illumina
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 M | 86 M | 71 M | 51 M | - | 45 M | 1.11 B | 10 M | 74.9 M | - | 304 M | 29.3 M | 37 M | 312 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.11 B | 10 M | 184 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 3.03 | -2.26 % | $ 98.3 K | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 23.35 | -2.91 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
838 K | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
173 M | $ 219.29 | -0.08 % | $ 160 B | ||
|
Exact Sciences Corporation
EXAS
|
27.4 M | $ 102.41 | 0.1 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 26.19 | -0.19 % | $ 792 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
29.2 M | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
DexCom
DXCM
|
21.1 M | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
5.94 M | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
172 K | $ 109.48 | -2.35 % | $ 4.32 B | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
1.87 M | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
3.38 M | $ 11.99 | -3.35 % | $ 1.52 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
99 M | $ 230.33 | -2.19 % | $ 41.8 B | ||
|
Charles River Laboratories International
CRL
|
54.2 M | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Personalis
PSNL
|
7.7 M | $ 9.33 | -6.42 % | $ 553 M | ||
|
Medpace Holdings
MEDP
|
23.3 M | $ 582.66 | -1.76 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
173 M | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Biodesix
BDSX
|
719 K | $ 10.11 | 4.66 % | $ 1.31 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
218 K | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
185 M | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
29.8 M | $ 1 370.47 | -1.61 % | $ 29.1 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 181.44 | -2.39 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
21.5 M | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 28.66 | -2.02 % | $ 20 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.41 | 0.84 % | $ 5.54 M |